Works matching IS 09147187 AND DT 2018 AND VI 32 AND IP 8

Results: 10

Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.

Published in:

2018

By:

Rahman, Mahmudur G M;
Islam, Muhammad M;
Tsujikawa, Tetsuya;
Kiyono, Yasushi;
Okazawa, Hidehiko

Publication type:

journal article

Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications.

Published in:

2018

By:

Werner, Rudolf A.;
Bundschuh, Ralph A.;
Bundschuh, Lena;
Javadi, Mehrbod S.;
Higuchi, Takahiro;
Weich, Alexander;
Sheikhbahaei, Sara;
Pienta, Kenneth J.;
Buck, Andreas K.;
Pomper, Martin G.;
Gorin, Michael A.;
Lapa, Constantin;
Rowe, Steven P.

Publication type:

journal article

CXCR4-directed theranostics in oncology and inflammation.

Published in:

2018

By:

Kircher, Malte;
Herhaus, Peter;
Schottelius, Margret;
Buck, Andreas K.;
Werner, Rudolf A.;
Wester, Hans-Jürgen;
Keller, Ulrich;
Lapa, Constantin

Publication type:

journal article

Detectability of residual invasive bladder cancer in delayed 18F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling.

Published in:

2018

By:

Higashiyama, Akira;
Komori, Tsuyoshi;
Juri, Hiroshi;
Inada, Yuki;
Azuma, Haruhito;
Narumi, Yoshifumi

Publication type:

journal article

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.

Published in:

2018

By:

Seider, Michael J.;
Pugh, Stephanie L.;
Langer, Corey;
Wyatt, Gwen;
Demas, William;
Rashtian, Afshin;
Clausen, Cathy L.;
Derdel, Jerome David;
Cleary, Sean F.;
Peters, Christopher A.;
Ramalingam, Ashok;
Clarkson, James E.;
Tomblyn, Michael;
Rabinovitch, Rachel A.;
Kachnic, Lisa A.;
Berk, Lawrence B.;
for the NRG Oncology;
NRG Oncology

Publication type:

journal article

Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer.

Published in:

2018

By:

Komek, Halil;
Can, Canan;
Yilmaz, Ugur;
Altindag, Serdar

Publication type:

journal article

Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate.

Published in:

2018

By:

Escala Cornejo, Roberto A.;
García-Talavera, Paloma;
Navarro Martin, Miguel;
Pérez López, Berta;
García Muñoz, María;
Tamayo Alonso, Ma. Pilar;
Cruz Hernández, Juan J.

Publication type:

journal article

Reproducibility of standardized uptake values of same-day randomized 68Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients.

Published in:

2018

By:

Ringheim, Anna;
Campos Neto, Guilherme de Carvalho;
Martins, Karine Minaif;
Vitor, Taise;
da Cunha, Marcelo Livorsi;
Baroni, Ronaldo Hueb

Publication type:

journal article

Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.

Published in:

2018

By:

Albano, Domenico;
Bertoli, Mattia;
Battistotti, Marco;
Rodella, Carlo;
Statuto, Massimo;
Giubbini, Raffaele;
Bertagna, Francesco

Publication type:

journal article

Diagnosing polymyalgia rheumatica on 18F-FDG PET/CT: typical uptake patterns.

Published in:

2018

By:

Yuge, Shunsuke;
Nakatani, Koya;
Yoshino, Kumiko;
Koyama, Takashi

Publication type:

journal article

Works matching IS 09147187 AND DT 2018 AND VI 32 AND IP 8

Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.

Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications.

CXCR4-directed theranostics in oncology and inflammation.

Detectability of residual invasive bladder cancer in delayed <sup>18</sup>F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling.

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.

Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer.

Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate.

Reproducibility of standardized uptake values of same-day randomized <sup>68</sup>Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients.

Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.

Diagnosing polymyalgia rheumatica on <sup>18</sup>F-FDG PET/CT: typical uptake patterns.